<DOC>
	<DOCNO>NCT01939743</DOCNO>
	<brief_summary>Transrectal ultrasound guide biopsy prostate ( TRUS-Bx ) widely use accept mode investigation prostate cancer current urology practice . It consider minor procedure , patient tolerate , however 20 % patient refuse undergo redo procedure without analgesia anesthesia hand , author reveal 65 90 % patient report pain range mild severe intensity . Diclofenac local systemic anti-inflammatory drug reduces local mediator involve local pain.The purpose study find role rectal administration diclofenac suppository adjunct 2 % xylocaine gel alleviate intra post procedural pain prostatic biopsy adequately calculate sample size exclude patient contraindication procedure diclofenac administration shortcoming previous study .</brief_summary>
	<brief_title>Efficacy Diclofenac Suppository Pain Control Ultrasound Guided Biopsy Prostate</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>All male patient undergo ultrasound guide prostate biopsy due one following : Raised prostatespecific antigen level ( &gt; 4.0ng/ml ) palpable nodularity digital rectal examination Palpable nodularity digital rectal examination Hypo echoic lesion compare surround prostate transrectal ultrasound History previous prostate biopsy Acute and/or chronic prostatitis chronic pelvic pain syndrome Anal fissure , hemorrhoid , anal surgery Concomitant analgesic medication Chronic renal failure Allergy diclofenac</criteria>
	<gender>Male</gender>
	<minimum_age>51 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>